TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 68 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $705,000 | -5.0% | 526,454 | -19.8% | 0.00% | 0.0% |
Q4 2018 | $742,000 | -69.6% | 656,378 | -25.8% | 0.00% | -66.7% |
Q3 2018 | $2,441,000 | -7.3% | 884,415 | +19.9% | 0.01% | -18.2% |
Q2 2018 | $2,634,000 | -48.8% | 737,715 | -55.9% | 0.01% | -54.2% |
Q1 2018 | $5,140,000 | – | 1,674,341 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 330,000 | $2,353,000 | 0.98% |
EcoR1 Capital, LLC | 633,400 | $4,516,000 | 0.80% |
DLD Asset Management, LP | 570,000 | $4,059,000 | 0.53% |
Rhenman & Partners Asset Management AB | 300,000 | $2,139,000 | 0.31% |
Eventide Asset Management | 600,000 | $4,278,000 | 0.27% |
Tekla Capital Management LLC | 1,004,322 | $7,161,000 | 0.26% |
Rock Springs Capital Management LP | 698,000 | $4,977,000 | 0.25% |
DLD Asset Management, LP | 230,000 | $1,640,000 | 0.21% |
Worth Venture Partners, LLC | 29,325 | $209,000 | 0.18% |
Crestline Management, LP | 161,403 | $1,151,000 | 0.15% |